In recent years, nanoparticles have evolved to a clinical modality to deliver diverse nucleic
acids. Rising interest in nanomedicines comes from proven safety and efficacy profiles …

Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …

Biomedical applications with emphasis on the design of smart materials, specifically
magnetic nanoparticles (MNPs) are considered to have technological benefits because they …

Biomolecule-based nanostructures are inherently multifunctional and harbour diverse
biological activities, which can be explored for cancer nanomedicine. The supramolecular …

Metastasis remains a pivotal characteristic of cancer and is the primary contributor to cancer-
associated mortality. Despite its significance, the mechanisms governing metastasis are not …

Nanotechnology plays a significant role in the field of medicine and in drug delivery, mainly
due to the major limitations affecting the conventional pharmaceutical agents, and older …

Metastasis is the leading cause of cancer-related deaths; until now, the detection of tumor
metastasis is mainly located at the period that secondary tumors have been formed, which …

Biosensors with high sensitivity, selectivity and a low limit of detection, reaching
nano/picomolar concentrations of biomolecules, are important to the medical sciences and …

Nanomedicines for drug delivery and imaging-guided cancer therapy is a rapidly growing
research area. The unique properties of nanomedicines have a massive potential in solving …

Conspectus In 1995, the year the first cancer nanomedicine, Doxil, was approved by the
Food and Drug Administration (FDA), only 23 manuscripts appeared in a PubMed search for …